What we do
We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosages.
forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered-dose inhalers, and dry powder inhalers.
Our mission is to contribute toward improving patients’ quality of life across the globe, by providing effective and accessible medicines.
Our Vision
High Quality
Affordability
Ethics & standards
Innovative
Our Expertise
We are present across varied therapies such as antituberculosis, antimalarials, antiretrovirals, antibacterial, antidiabetic, antihypertensive, and antiasthmatics. We are also known for the number of WHO prequalified medicines, used in the treatment of
HIV/AIDS, Malaria, Tuberculosis (TB), and opportunistic infections.
Our Products
- Rusozee 500(Azithromycin Anhydrous 500mg)
- Rufixime 200(Cefixime 200mg Tab)
- Rufixime CV(Cefixime 200mg + Clavilnic Acid 125mg)
- Rusoclav 625(Amoxicillin 500mg + Clavulnic Acid 125mg)
- RusoFlex 0(Ofioxacin IP 200mg + Ornidazole IP 500mg)
- RusoWorm A(Albandazole IP 400mg + Ivermectin 6mg )
Our Clients
